Preliminary results of a randomized, double blind, placebo controlled trial on osteoarthritis of the knee using ActiPatch Therapy have been announced.
BioElectronics Corporation says the initial interim analysis showed statistically significant results for the primary and secondary outcomes measures. The study is being led by Doctor Gianluca Bagnato, Division of Rheumatology, University Hospital Gaetano Martino, Messina, Italy. The final analysis of the full study data set will be carried out soon and the results have been accepted in the Annals of the Rheumatic Diseases and presented at the European League against Rheumatism 2014 conference.
"The completion of these randomized, placebo controlled trials, on pain resulting from three very distinct musculoskeletal pathophysiological processes, is highly significant," commented Andrew Whelan, BioElectronics CEO. "The data from these high quality clinical trials will be available before the FDA's May 21st deadline for comments on proposed reclassification of our devices to Class II. This schedule will allow us to submit the 510K application without any delay once the final ruling is made by the FDA."
BioElectronics is conducting a series of clinical research studies using its medical devices for other musculoskeletal pain conditions that include, acute nonspecific lower back pain, as well as the surgical indications of postoperative recovery for 3rd molar extraction and hernia repair.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Family Holiday Survival: 12 Ways To Deal With That Climate Change Denier
- A Vegetarian Carnivorous Plant...Wait, What?
- Falsifiability And The Integrity Of Physics
- Wave-Particle Duality And Quantum Uncertainty - Two Sides Of The Same Mystery?
- Guest Post: Ben Allanach, On Open Access
- How Does Prostate Cancer Happen?
- Enlightenment Finding Eternity In The Now
- "Love this. Short, simple, to the point, and it applies in oh so many ways to many far-flung..."
- "First off, Popperian falsifiability doesn't fit well into the realities of Science, since the likelihood..."
- "There is a guideline in science; when someone outside science invokes Popper, they probably don't..."
- "Anon.:Postdictions are certainly important. However, they are only the first of two steps..."
- "Yes, I meant toxic or harmful chemicals. I suppose you live in an area which is prone to heavy..."
- Blocking excessive division of cell powerhouses reduces liver cell death in cholestasis
- Study reveals major websites could be doing more to promote improved password security
- New technology makes tissues, someday maybe organs
- Suppressing a protein reduces cancer spread in mice
- Study: An alternative for pain control after knee replacement surgery